GDC563d49
Homo sapiens
source_name
BL0269 human bladder cancer patient-derived xenograft (PDX)
phenotype
Pictilisib (GDC-0941)-resistant
drug treatment
Pictilisib (GDC-0941) (100 mg/kg P.O.)
duration of drug treatment
49 days